Clinical trial
Effect of Donepezil on Speech Recognition in Cochlear Implant Users
NCT05438264 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Donepezil on Speech Recognition in Cochlear Implant Users
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 10, 2023
- Completion date
- October 1, 2026
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bilateral sensorineural hearing loss